The application of metabolomics to epidemiologic studies is increasing.
Aim of Review
Here, we describe the challenges and opportunities facing early-career epidemiologists aiming to apply metabolomics to their research.
Key Scientific Concepts of Review
Many challenges inherent to metabolomics may provide early-career epidemiologists with the opportunity to play a pivotal role in answering critical methodological questions and moving the field forward. Although generating large-scale high-quality metabolomics data can be challenging, data can be accessed through public databases, collaboration with senior researchers or participation within interest groups. Such efforts may also assist with obtaining funding, provide knowledge on training resources, and help early-career epidemiologists to publish in the field of metabolomics.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Alkawaa, F. M., et al. (2017). Deep learning accurately predicts estrogen receptor status in breast cancer metabolomics data. Journal of Proteome Research, 17(1), 337–347.
Assi, N., et al. (2015). A statistical framework to model the meeting-in-the-middle principle using metabolomic data: Application to hepatocellular carcinoma in the EPIC study. Mutagenesis, 30(6), 743–753.
Baldassarre, M. E., et al. (2018). Effectiveness and safety of a probiotic-mixture for the treatment of infantile colic: A double-blind, randomized, placebo-controlled clinical trial with fecal real-time PCR and nmr-based metabolomics analysis. Nutrients, 10(2), 195.
Bictash, M., et al. (2010). Opening up the “Black Box”: Metabolic phenotyping and metabolome-wide association studies in epidemiology. Journal of Clinical Epidemiology, 63(9), 970–979.
Broadhurst, D., et al. (2018). Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics, 14(6), 72.
Carayol, M., et al. (2017). Blood metabolic signatures of body mass index: A targeted metabolomics study in the EPIC cohort. Journal of Proteome Research, 16(9), 3137–3146.
Cheng, S., et al. (2017). Potential impact and study considerations of metabolomics in cardiovascular health and disease: A scientific statement from the American Heart Association. Circulation Cardiovascular Genetics, 10(2), e000032.
Cross, A. J., et al. (2014). A prospective study of serum metabolites and colorectal cancer risk. Cancer, 120(19), 3049–3057.
Cui, L., et al. (2016). Serum metabolomics reveals serotonin as a predictor of severe dengue in the early phase of dengue fever. PLoS Neglected Tropical Diseases, 10(4), e0004607.
Derkach, A., et al. (2017). Effects of dietary sodium on metabolites: The dietary approaches to stop hypertension (DASH)-sodium feeding study. The American Journal of Clinical Nutrition, 106(4), 1131–1141.
Dudzik, D., et al. (2018). Quality assurance procedures for mass spectrometry untargeted metabolomics. A review. Journal of Pharmaceutical and Biomedical Analysis, 147, 149–173.
Fages, A., et al. (2014). Investigating sources of variability in metabolomic data in the EPIC study: The principal component partial R-square (PC-PR2) method. Metabolomics, 10(6), 1074–1083.
Fages, A., et al. (2015). Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Medicine, 13, 242.
Floegel, A., et al. (2013). Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes, 62(2), 639–648.
Floegel, A., et al. (2018). Serum metabolites and risk of myocardial infarction and ischemic stroke: A targeted metabolomic approach in two German prospective cohorts. European Journal of Epidemiology, 33(1), 55–66.
Guertin, K. A., et al. (2015). Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. American Journal of Clinical Nutrition, 101(5), 1000–1011.
Hernandes, V. V., et al. (2017). A review of blood sample handling and pre-processing for metabolomics studies. Electrophoresis, 38(18), 2232–2241.
Ho, J. E., et al. (2016). Metabolomic profiles of body mass index in the framingham heart study reveal distinct cardiometabolic phenotypes. PLoS ONE, 11(2), e0148361.
Holmes, E., et al. (2008). Human metabolic phenotype diversity and its association with diet and blood pressure. Nature, 453(7193), 396–400.
Hrydziuszko, O., & Viant, M. R. (2012). Missing values in mass spectrometry based metabolomics: An undervalued step in the data processing pipeline. Metabolomics, 8(1), 161–174.
Huang, J., et al. (2016). Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. British Journal of Cancer, 115(9), 1087–1095.
Huang, S., et al. (2016). Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis. Genome Medicine, 8(1), 34.
Ke, C., et al. (2015). Large-scale profiling of metabolic dysregulation in ovarian cancer. International Journal of Cancer, 136(3), 516–526.
Kirwan, J. A., et al. (2018). Preanalytical processing and biobanking procedures of biological samples for metabolomics research: A white paper, community perspective (for “precision Medicine and pharmacometabolomics task group"-the metabolomics society initiative). Clinical Chemistry, 64(8), 1158–1182.
Liesenfeld, D. B., et al. (2013). Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiology Prevention Biomarkers, 22(12), 2182–2201.
Loftfield, E., et al. (2016). Comparison of collection methods for fecal samples for discovery metabolomics in epidemiologic studies. Cancer Epidemiology Prevention Biomarkers, 25(11), 1483–1490.
Mathe, E. A., et al. (2014). Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Research, 74(12), 3259–3270.
Menni, C., et al. (2013). Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes, 62(12), 4270–4276.
Molins, C. R., et al. (2015). Development of a metabolic biosignature for detection of early Lyme disease. Clinical Infectious Diseases, 60(12), 1767–1775.
Mondul, A. M., et al. (2015). Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study. International Journal of Cancer, 137(9), 2124–2132.
Moore, S. C., et al. (2014). Human metabolic correlates of body mass index. Metabolomics, 10(2), 259–269.
Moore, S. C., et al. (2018). A metabolomics analysis of body mass index and postmenopausal breast cancer risk. Journal of National Cancer Institute, 110(6), 588–597.
Nishiumi, S., et al. (2012). A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS ONE, 7(7), e40459.
Playdon, M. C., et al. (2017). Nutritional metabolomics and breast cancer risk in a prospective study. The American Journal of Clinical Nutrition, 106(2), 637–649.
Ren, S., et al. (2015). Computational and statistical analysis of metabolomics data. Metabolomics, 11(6), 1492–1513.
Saccenti, E., et al. (2014). Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics, 10(3), 361–374.
Scalbert, A., et al. (2009). Mass-spectrometry-based metabolomics: Limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics, 5(4), 435–458.
Stepien, M., et al. (2016). Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study. International Journal of Cancer, 138(2), 348–360.
Su, L. J., et al. (2014). The use of metabolomics in population-based research. Advances in Nutrition, 5(6), 785–788.
Sumner, L. W., et al. (2007). Proposed minimum reporting standards for chemical analysis. Metabolomics, 3(3), 211–221.
Townsend, M. K., et al. (2013). Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clinical Chemistry, 59(11), 1657–1667.
Tzoulaki, I., et al. (2014). Design and analysis of metabolomics studies in epidemiologic research: A primer on -omic technologies. American Journal of Epidemiology, 180(2), 129–139.
Wang, T. J., et al. (2011). Metabolite profiles and the risk of developing diabetes. Nature Medicine, 17(4), 448–453.
Wang-Sattler, R., et al. (2012). Novel biomarkers for pre-diabetes identified by metabolomics. Molecular Systems Biology, 8, 615.
Welsh, P., et al. (2018). Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: Results from the advance trial. Diabetologia, 61(7), 1581–1591.
Wurtz, P., et al. (2015). Metabolite profiling and cardiovascular event risk: A prospective study of 3 population-based cohorts. Circulation, 131(9), 774–785.
Xiao, Q., et al. (2014). Sources of variability in metabolite measurements from urinary samples. PLoS ONE, 9(5), e95749.
Zanetti, K., et al. (2014). The future of metabolomic profiling in population-based research: Opportunities and challenges. Journal of Analytical and Bioanalytical Techniques, 5, 203.
Zheng, Y., et al. (2013a). Associations between metabolomic compounds and incident heart failure among African Americans: The ARIC Study. American Journal of Epidemiology, 178(4), 534–542.
Zheng, Y., et al. (2013b). Metabolomics and incident hypertension among blacks: The atherosclerosis risk in communities study. Hypertension, 62(2), 398–403.
E.H. van Roekel was financially supported by Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme (Grant No. 2016/1620) and the GROW School for Oncology and Developmental Biology. E. Loftfield was supported by the Intramural Research Program of the National Institutes of Health, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services. R.S. Kelly was supported by a Discovery Award from The US Department of Defense (Grant No. W81XWH-17-1-0533), and a grant from the US NIH (Grant No. 1R01HL123915-01). O.A. Zeleznik was supported by grants from the NIH (Grant Nos. CA087969, CA050385). K.A. Zanetti was supported by the Extramural Research Program of the National Institutes of Health, Division of Cancer Control and Populations Sciences, National Cancer Institute, Department of Health and Human Services.
Conflict of interest
All authors declare that they do not have conflict of interest.
Research involving human and/or animal participants
This article does not contain any studies with human and/or animal participants performed by any of the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
van Roekel, E.H., Loftfield, E., Kelly, R.S. et al. Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists. Metabolomics 15, 9 (2019). https://doi.org/10.1007/s11306-018-1468-z
- Early-career scientists